Nevirapine Hemihydrate is the pediatric version of the HIV drug Nevirapine. Boehringer Ingelheim, the patent-holder, has been involved in licensing arrangements and competition settlements over this drug. The Indian Patent Office rejected the patent in this case. Read more HERE.
I-MAK Patent Opposition
Links to Selected Media on Indian Patent challenge
India rejects Boehringer's AIDS drug patent plea - The Times of India
Govt turns down German pharma firm`s patent plea - Business Standard
It's a relief for the HIV-infected - Deccan Herald
Competition Case and Settlement on Nevirapine
TAC agreements with GlaxoSmithKline and Boehringer Ingelheim in force", AIDS Law Project